Startups are facing uphill battles in getting their message across, inviting investors, marketing products, and securing financial boost. All the more if it is a biotech company, which makes things doubly harder. The industry is booming, but fewer biotech startups are becoming successful. What could be the reason behind it, and more importantly, how can they achieve greater success?
According to AlleyWatch, the cost of releasing a new drug in the market is almost $350 million, with the trend increasing as time goes by. Aside from the huge financial requirement, biotech startups must also undergo the time-consuming process of securing an approval from the U.S. Food and Drug Administration (FDA). If a single step is missed, it could hunt the founders and be a reason why it will fail to get approval from FDA.
Another reason is that releasing a drug takes countless studies, experiments and research. With drugs, it can work sometimes, while in other circumstances, they don’t. But biotech startups need not lose faith as there is one way to increase their chances of success: crowdfunding.
Venture capital (VC) funding has always been the go-to solution for biotechs in the U.K. However, it is high time to explore other viable alternatives such as crowdfunding. From 2014 to 2015, crowdfunding grew by as much as 295 percent in the U.K., per Lexology, and experts agree it could soon replace venture capital as a top source of financial needs. One of the reasons why crowdfunding is enjoying relative success in the biotech industry is the possibility of quickly raising money and providing access to it.
Eyebrain, a biotech startup, serves as proof that crowdfunding is better than venture capitalists. It secured its first tranche of money in under 90 days compared to the nine months in VC funding. Since 2014, online crowdfunding platforms supporting life sciences have been increasing. In the U.S., there are Poliwogg and Medstartr, while in the U.K., there is Syndicate Room.
A startup can secure an average capital of £400,000 in Europe, but there are also those that have reached the million-pound mark such as Cell Therapy, Eyebrain and Riboxx. Capital Cell was able to raise £3.77 million after launching 14 successful campaigns. Now, investors are starting to reap early returns on investment, making early funding crucial. If everything goes well, it’s a win-win situation for investors and entrepreneurs.
The success of a startup is not only dependent on financial assistance. Communication is also vital in such a way that a crowdfunding campaign tells the story of the product or service that is being offered and why there is a need for it in the current market. Choosing the correct platform is crucial as well. Entrepreneurs and founders must exercise due diligence when choosing where to launch their crowdfunding campaign.
To avoid failure, entrepreneurs in the biotech startups are encouraged to take crash courses on regulatory science, AlleyWatch stated in the same article. In this way, they can get the necessary information on legal and ethical issues that they may face along the way.
5 major things to look for when buying your first home
Save yourself from the headache of buying a house with these helpful tips such as looking for hidden issues, and...
4 ways mobile technology can boost your business
Mobile technology has changed the way people do business, as well as the consumer habits. Here's how it helps you...
How farmers are handling the rising costs of equipment
American farmers are hit hard by the demands of rising competition, land costs and advancements in equipment. Balancing the need...
Apple could stay in bear market territory until next year
The decline of Apple stock that worsen after the company’s fourth-quarter report may persist until next year, pushing the stock...
Earthquake highlights need to overhaul Port of Alaska
While the recent Alaskan quake spared the Port of Alaska, the state recognizes that a major overhaul is due for...
Featured3 days ago
CEOs Fishkin and Ramsay: From financial burdens to million-dollar companies
Destinations3 days ago
Millennials with money escape to Mexico’s Bohemian luxury
Entrepreneurship5 days ago
How to make the best out of email marketing
Business4 days ago
Disney continues quest to buy Fox, Brazilian regulators raise concerns
Business5 days ago
GlaxoSmithKline to acquire Tesaro to strengthen pharmaceuticals business
Sponsored3 days ago
The Alkaline Water Co. begins trading on NASDAQ today
Sponsored2 days ago
Cannabis retailer Choom secures leadership position with Ontario expansion
Business4 days ago
IoT and LaaS mean stronger growth for LED market